Generic · Tablet · Updated Nov 11, 2026
Entecavir 1 mg tablet price what pharmacies pay, and what you should
Is my price fair?
Check the price you were quoted
Type what the pharmacy asked for entecavir 1 mg tablet and see the markup over what they pay.
A benchmark from public data, not a price offer or medical advice. Prices vary by pharmacy, insurance and discount programs.
Entecavir 1 mg price history
What pharmacies pay for 30 tablets, weekly- Now
- $10.74
- 52-week low
- $9.36
- 52-week high
- $14.66
- A year ago
- $14.06
Why the price changed
| Effective | Before | After | Change | Reason |
|---|---|---|---|---|
| Oct 21, 2026 | $0.3684 | $0.3579 | -2.9% | pharmacies' invoice prices changed (survey) |
| Sep 23, 2026 | $0.3658 | $0.3684 | +0.7% | pharmacies' invoice prices changed (survey) |
| Aug 19, 2026 | $0.3520 | $0.3658 | +3.9% | pharmacies' invoice prices changed (survey) |
| Jul 22, 2026 | $0.3501 | $0.3520 | +0.5% | pharmacies' invoice prices changed (survey) |
| Jun 17, 2026 | $0.3607 | $0.3501 | -2.9% | pharmacies' invoice prices changed (survey) |
| May 20, 2026 | $0.3680 | $0.3607 | -2.0% | pharmacies' invoice prices changed (survey) |
| Apr 22, 2026 | $0.3513 | $0.3680 | +4.8% | pharmacies' invoice prices changed (survey) |
| Mar 18, 2026 | $0.3119 | $0.3513 | +12.6% | pharmacies' invoice prices changed (survey) |
Prices per tablet. Reasons are the ones the national survey gives: a survey rate change comes from pharmacies' own invoices; a published price change follows the maker's list price.
What people paid for entecavir 1 mg tablet
What did your pharmacy charge? It takes 30 seconds, it's anonymous - and it shows everyone which pharmacies are fair.
Supply status: shortages & recalls
Recalls
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
Every manufacturer and package code
8 companies sell entecavir 1 mg tablet under 9 package codes (NDCs). Pharmacies pay the same per tablet whichever maker they buy from - the national average is set for the generic as a group.
| Maker | Package codes | Per unit |
|---|---|---|
| Aurobindo Pharma Limited | 65862-842-30 | $0.3579 |
| Camber Pharmaceuticals, Inc. | 31722-834-30 | $0.3579 |
| Cameron Pharmaceuticals | 42494-458-30 | $0.3579 |
| Cipla USA Inc. | 69097-425-02 | $0.3579 |
| Epic Pharma, LLC | 42806-659-30 42806-668-30 | $0.3579 |
| NorthStar RxLLC | 16714-718-01 | $0.3579 |
| Solco Healthcare LLC | 43547-437-03 | $0.3579 |
| Zydus Pharmaceuticals USA Inc. | 68382-921-06 | $0.3579 |
All 9 package codes
A dash means no weekly price for that maker's packages. Which maker your pharmacy stocks usually doesn't change what you pay, but you can ask.
Questions to ask your pharmacist
- "What is your cash price, without insurance?" For low-cost generics it can be less than a copay.
- "Is a 90-day supply cheaper per tablet?" Dispensing fees are charged per fill, so fewer fills often cost less.
- "Would 0.5 mg tablet work for me instead?" Pharmacies pay $0.2460 per tablet for it, against $0.3579 for this one. Only your prescriber can say whether a different strength or form suits you.
- "Do you match other pharmacies or accept discount cards?" Many do, if you ask.
These are questions, not advice. Never change how you take a medicine without talking to your prescriber or pharmacist.
Other entecavir strengths and forms
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 0.5 mg tablet | $0.2460 | $7.38 / 30 tablets |
Official label & what changed
These highlights do not include all the information needed to use ENTECAVIR TABLETS safely and effectively. See full prescribing information for ENTECAVIR TABLETS. ENTECAVIR tablets, for oral use Initial U.S. Approval: 2005
WARNING: SEVERE ACUTE EXACERBATIONS OF HEPATITIS B, PATIENTS CO-INFECTED WITH HIV AND HBV, AND LACTIC ACIDOSIS AND HEPATOMEGALY
WARNING: SEVERE ACUTE EXACERBATIONS OF HEPATITIS B, PATIENTS CO-INFECTED WITH HIV AND HBV, and LACTIC ACIDOSIS AND HEPATOMEGALY
Severe acute exacerbations of hepatitis B have been reported in patients who have discontinued anti-hepatitis B therapy, including entecavir. Hepatic function should be monitored closely with both clinical and laboratory follow-up for at least several months in patients who discontinue anti-hepatitis B therapy. If appropriate, initiation of anti-hepatitis B therapy may be warranted
[see Warnings and Precautions (
5.1)].
Limited clinical experience suggests there is a potential for the development of resistance to HIV (human immunodeficiency virus) nucleoside reverse transcriptase inhibitors if entecavir is used to treat chronic hepatitis B virus (HBV) infection in patients with HIV infection that is not being treated. Therapy with entecavir is not recommended for HIV/HBV co-infected patients who are not also receiving highly active antiretroviral therapy (HAART)
[see Warnings and Precautions (
5.2)].
Lactic acidosis and severe hepatomegaly with steatosis, including fatal cases, have been reported with the use of nucleoside analogue inhibitors alone or in combination with antiretrovirals
[see Warnings and Precautions (
5.3)].
WARNING: SEVERE ACUTE EXACERBATIONS OF HEPATITIS B, PATIENTS CO-INFECTED WITH HIV AND HBV, and LACTIC ACIDOSIS AND HEPATOMEGALY
See full prescribing information for complete boxed warning.•
Severe acute exacerbations of hepatitis B have been reported in patients who have discontinued anti-hepatitis B therapy, including entecavir. Hepatic function should be monitored closely for at least several months after discontinuation. Initiation of anti-hepatitis B therapy may be warranted. (
5.1)
•
Entecavir is not recommended for patients co-infected with human immunodeficiency virus (HIV) and hepatitis B virus (HBV) who are not also receiving highly active antiretroviral therapy (HAART), because of the potential for the development of resistance to HIV nucleoside reverse transcriptase inhibitors. (
5.2)
• Lactic acidosis and severe hepatomegaly with steatosis, including fatal cases, have been reported with the use of nucleoside analogue inhibitors. (
5.3)
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Questions about entecavir 1 mg tablet
How much does entecavir 1 mg tablet cost without insurance?
Pharmacies pay about $10.74 for 30 tablets ($0.3579 per tablet) as of November 11, 2026. A fair cash price is about $22.85: that cost plus a 15% margin and a $10.50 dispensing fee. Online cost-plus pharmacies charge around $22.35 including shipping.
Is my price for entecavir 1 mg tablet fair?
Compare it with the fair cash price of $22.85 for 30 tablets. Up to about $28.56 is fair; above $45.70 is high, and worth asking the pharmacy for its cash price or trying another pharmacy. Check your quote.
Is entecavir 1 mg tablet getting more expensive?
Over the last four weeks the price pharmacies pay fell 2.9%. Over a year it fell 23.6%. See the 52-week chart.
Who makes entecavir 1 mg tablet?
8 companies: Aurobindo Pharma Limited, Camber Pharmaceuticals, Inc., Cameron Pharmaceuticals, Cipla USA Inc., Epic Pharma, LLC, NorthStar RxLLC, Solco Healthcare LLC, Zydus Pharmaceuticals USA Inc.. See every package code.
Is entecavir in shortage?
No shortage is reported right now. We check every day.
Has entecavir been recalled?
6 recalls on record, 4 ongoing. Recalls name specific lots - check yours.
What does "pharmacies pay" mean?
It's the national average price retail pharmacies pay wholesalers and makers to buy the drug, from a weekly government survey of pharmacy invoices. It doesn't include the pharmacy's costs of filling a prescription, which is why the fair price adds a margin and a dispensing fee. How we work it out.
Talk about entecavir 1 mg tablet
No comments yet. Questions, tips, what worked for you - start the conversation.